fbpx

Updates

New Content in the past 2 weeks

Recently

New

New

Symposium on 'Fixed-dose combinations for CVD and hypertension' at the London School of Hygiene & Tropical Medicine

A symposium on “Fixed-dose combinations for cardiovascular disease and hypertension: Perspectives and lessons learned from HIV/AIDS and TB” will be held at the London School of Hygiene and Tropical Medicine on July 3rd from 9am to 5pm.

The Global Centre for Chronic Conditions at LSHTM, the George Institute for Global Health, Sydney and Médecins sans Frontières will co-host this symposium.

Fixed-dose combinations (FDC) for prevention of atherosclerotic cardiovascular disease (CVD), including FDCs for secondary prevention and hypertension, have shown promising results but progress on their uptake and use has been slow. Notably, applications to include these FDCs for secondary prevention and hypertension in the World Health Organization (WHO) Essential Medicine List (EML) have not been successful.

This international symposium will bring experts working on FDCs for CVD and hypertension together with experts working in the fields of HIV and TB, as well as representatives from governmental, non-governmental organizations, industry and funders. The final aim is to provoke a lively discussion around the barriers to FDC implementation, particularly in relation to the EML and to explore the next steps in moving this agenda forward through further research, advocacy and policy change.

Professor Baron Peter Piot, Director of the London School of Hygiene & Tropical Medicine, will give the welcome address and speakers will include Dr Helen Bygrave, MSF Access Campaign, Dr Ruth Webster, The George Institute for Global Health, Dr Stephen MacMahon, Professor of Global Health, University of Oxford, and Dr Giorgio Roscigno, Global Alliance for TB Drug Development and representatives from the World Health Organization, among others.

Register here